Business
CEO of Mindset Pharma, James Lanthier, gives us an overview of his company and the 4 new psychedelics they are...
This week in psychedelic business news: Mindset Pharma partners with global pharmaceutical company; Awakn Life Sciences explores behavioral addictions; Ei.Ventures...
Whether or not psychedelic medicines will become legalized to treat patients with mental health conditions will ultimately rest on whether...
It’s yet another sign that the pharmaceutical industry at large is taking the potential of psychedelics very seriously....
This week in psychedelic business news: Mindset Pharma files another patent for compounds with "perfect microdosing drug profile," and Core...
Our resident Psychedelic Investor looks back at some of this growing industry's biggest moments and how they may shape the...
The psychedelic medicines industry had a revolutionary year in 2021. At the start of the year, there were only a...
Co-Founder and CEO, Matt Stang, gives us an overview of the company's clinics, Delic Labs and more....
This week in psychedelic business news: FDA green lights a new psilocybin study; MindMed commences LSD treatment for ADHD; Sage...
MindMed (Nasdaq:MNMD, NEO:MMED) has launched recruitment for their phase 2a clinical trial, testing using LSD microdoses to treat Adult ADHD!...